Results 51 to 60 of about 1,255 (166)
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
British Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis +16 more
wiley +1 more source
Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update
Journal of Ultrasound in Medicine, Volume 44, Issue 3, Page 381-433, March 2025.A 2012 review of therapeutic ultrasound was published to educate researchers and physicians on potential applications and concerns for unintended bioeffects (doi: 10.7863/jum.2012.31.4.623). This review serves as an update to the parent article, highlighting advances in therapeutic ultrasound over the past 12 years.
Kenneth B. Bader +40 more
wiley +1 more source
Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +2 more sources
Case Reports in Dentistry, 2014 Intravascular papillary endothelial hyperplasia or Masson’s tumor is a rare reactive disease of vascular origin characterized by exuberant proliferation of endothelial cells notably occurring within blood vessels of head, neck, and extremities.
Mahima V. Guledgud +4 more
doaj +1 more source
Masson′s hemangioma: A rare intraoral presentation
Contemporary Clinical Dentistry, 2013 An otherwise healthy 19-year-old female patient had painless swelling in her left buccal mucosa. No precipitating factors were identified. Pathological analysis demonstrated the mass to be a Masson′s hemangioma, a papillary proliferation of thin-walled ...
Anjali Narwal +3 more
doaj +1 more source
Intravascular lesions of the hand
Diagnostic Pathology, 2008 Introduction Intravascular lesions of the hand comprise reactive and neoplastic entities. The clinical diagnosis of such lesions is often difficult, and usually requires pathologic examination.
Duke Wayne H, Pantanowitz Liron
doaj +1 more source
Intravascular papillary endothelial hyperplasia.
Archives of pathology & laboratory medicine, 1976 Papillary endothelial hyperplasia is a peculiar benign intravascular process that bears a remarkable resemblance to a hemangiosarcoma. In 44 cases of this lesion studied from the files of the Armed Forces Institute of Pathology, the process manifested as a small tumor-like lesion that occurred most frequently in the subcutis of the fingers (14 cases ...
K P, Clearkin, F M, Enzinger
openaire +1 more source
The Turkish Journal of Pediatrics, 2005 Intravascular papillary endothelial hyperplasia (IPEH) is a rare benign endothelial proliferation that bears a remarkable resemblance to angiosarcoma.
Ciğdem Tokyol +2 more
doaj
Intravascular Papillary Endothelial Hyperplasia (Masson’s Tumor) of the Mouth – A Case Report
Case Reports in Dermatology, 2010 We report a rare case of intravascular papillary endothelial hyperplasia (IPEH) of the oral mucosa. This neoplasm, known as Masson’s tumor, is an unusual vascular lesion of proliferating endothelial cells.
Ronell Bologna-Molina +5 more
doaj +1 more source
Indian Journal of Dental Research, 2015 Intravascular papillary endothelial hyperplasia (IPEH) is an unusual reactive lesion of vascular origin, which rarely occurs in the oral cavity. Pathogenetically, is it divided into true, mixed and extra-vascular types. We report a case of extra-vascular
G S Sarode, S C Sarode
doaj +1 more source